Gemcitabine. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer.
about
Human UMP-CMP kinase 2, a novel nucleoside monophosphate kinase localized in mitochondriaCombined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II studyPreclinical in vivo antitumor efficacy of nedaplatin with gemcitabine against human lung cancer.Phase I dose escalation study of gemcitabine plus irinotecan in advanced solid tumors.PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106)1: antitumor effect and mechanism of action.Modular polymer-caged nanobins as a theranostic platform with enhanced magnetic resonance relaxivity and pH-responsive drug release.Development of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer.Comparative testing of various pancreatic cancer stem cells results in a novel class of pancreatic-cancer-initiating cells.Gemcitabine combined with continuous infusion 5-fluorouracil in advanced and symptomatic pancreatic cancer: a clinical benefit-oriented phase II study.Gemcitabine plus vinorelbine in elderly or unfit patients with non-small cell lung cancer.Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung CancerDomiciliary chemotherapy with gemcitabine is safe and acceptable to advanced non-small-cell lung cancer patients: results of a feasibility study.Homozygous CDA*3 is a major cause of life-threatening toxicities in gemcitabine-treated Japanese cancer patients.Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma.Ethnic differences in the metabolism, toxicology and efficacy of three anticancer drugs.Synthesis and Biological Evaluation of 9-Deazaadenine 5'-Deoxy-6',6'-Difluoro-Carbocyclic C-Nucleoside Phosphonic Acid Derivatives.Digalloylresveratrol, a novel resveratrol analog inhibits the growth of human pancreatic cancer cells.Combination effects of digalloylresveratrol with arabinofuranosylcytosine and difluorodeoxycytidine in human leukemia and pancreatic cancer cells.Surface-modified gemcitabine with mucoadhesive polymer for oral delivery.Tumor-stroma interactions reduce the efficacy of adenoviral therapy through the HGF-MET pathway.A novel alkylating agent, glufosfamide, enhances the activity of gemcitabine in vitro and in vivo.Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile.Bcl-x(L) antisense oligonucleotides induce apoptosis and increase sensitivity of pancreatic cancer cells to gemcitabine.Gemcitabine and Chlorotoxin Conjugated Iron Oxide Nanoparticles for Glioblastoma Therapy.Gemcitabine hydrochloride-loaded functionalised carbon nanotubes as potential carriers for tumour targeting.Synthesis and antiviral evaluation of novel 2',2'-difluoro 5'-norcarbocyclic phosphonic acid nucleosides as antiviral agents.Gemcitabine-Induced Pulmonary Toxicity: A Case Report of Pulmonary Veno-Occlusive Disease.Gemcitabine, epirubicin and paclitaxel: pharmacokinetic and pharmacodynamic interactions in advanced breast cancer.Genotoxicity kinetics in murine normoblasts as an approach for the in vivo action of difluorodeoxycytidine.Synthesis and evaluation of novel 6',6'-difluoro 5'-deoxycarbocyclic phosphonic acid nucleosides as antiviral agents.A novel anticancer theranostic pro-prodrug based on hypoxia and photo sequential control.
P2860
Q24300329-5F84CE93-7CDB-4A10-8DDC-2616C2BC5F9BQ28364203-B31D95AD-F8B6-442F-93DF-78775BEA163FQ31927266-1A9793D3-4D8F-418D-822A-6010A4D713A0Q33387673-A44DB951-F991-4DEB-9358-9BDAD97CAD9BQ33404024-677A9988-49D3-4C52-9B0B-BFF3664FF591Q34373569-7FF3C50D-7CDB-424A-9344-94B35CD207B2Q34988879-FD88988C-EF1C-4AFE-8780-A6B9B4BB66E9Q36302124-86B21659-D032-4F50-BCD1-F4B44D811AACQ36374345-1B6E8DED-6B20-41E5-B0D3-108DB068ADFFQ36620908-C1F4CF38-862A-4906-82E0-9A64EAAEBCE5Q36621872-084E9604-EB2C-4E0B-92DA-C93DCEB3F892Q36642218-0AA45B6F-C7BA-4D2A-A4CB-46FB2C8276C1Q36673578-0C863DE9-0DE1-4B18-ACED-259C92663F30Q37141957-0B01E4E1-F72B-4090-A115-A0391B893AA9Q37326210-1A9F609E-1DA1-4597-A144-6A36FAD4F583Q37876401-DAD5C252-08F9-42C8-A6DD-5938EAF6FC6CQ38827914-8C2E4986-933A-46AE-BCCF-6026F1B82BBAQ39110541-776CCCB4-5877-41D7-B894-3AE08638FA84Q39434645-82B85F26-200E-42A3-AE29-BA6741ED7C09Q39588127-11FBA6F0-60FE-49CF-8132-8F72FC8D1E89Q39628107-3B215CB6-C799-416C-813C-AE966B294994Q40085159-332C8DAB-3519-4EF5-9821-88DB099A206AQ40460534-94A5C589-2CD8-4867-A28A-142047E93905Q40680294-27879D66-658F-4D14-83C7-ABB2687984C1Q41860499-ABC88FB9-9294-4ED0-A0BC-A95B12ED11A7Q41964915-13706B50-26DF-42D8-AF9A-A3D9DD995DFDQ42234101-5E5A4D83-3597-4405-939D-CA50A2BAF4AFQ43078253-3225414F-1AB2-4799-80D5-8B73EF9C20E2Q44067892-9CB64178-309B-44AE-A630-7ACE6B929025Q50785086-36AD3696-5A4A-4B1F-82E4-6124A2C5E9D2Q51872819-1932847F-02AA-43C0-A3C2-E88242058D77Q52981912-48AC9244-1E06-4D9C-8867-45C37E07FF49
P2860
Gemcitabine. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer.
description
1997 nî lūn-bûn
@nan
1997 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Gemcitabine. A review of its p ...... cancer and pancreatic cancer.
@ast
Gemcitabine. A review of its p ...... cancer and pancreatic cancer.
@en
Gemcitabine. A review of its p ...... cancer and pancreatic cancer.
@nl
type
label
Gemcitabine. A review of its p ...... cancer and pancreatic cancer.
@ast
Gemcitabine. A review of its p ...... cancer and pancreatic cancer.
@en
Gemcitabine. A review of its p ...... cancer and pancreatic cancer.
@nl
prefLabel
Gemcitabine. A review of its p ...... cancer and pancreatic cancer.
@ast
Gemcitabine. A review of its p ...... cancer and pancreatic cancer.
@en
Gemcitabine. A review of its p ...... cancer and pancreatic cancer.
@nl
P1433
P1476
Gemcitabine. A review of its p ...... cancer and pancreatic cancer.
@en
P304
P356
10.2165/00003495-199754030-00009
P577
1997-09-01T00:00:00Z
P6179
1011803547